The US Food and Drug Administration has issued a final rule amending its medical device regulations on how the agency publishes submission verdicts on premarket approval applications (PMAs) and humanitarian device exemptions (HDEs).
Effective on 14 February, the FDA is no longer publishing quarterly PMA and HDE approvals and denials in the Federal Register. The final rule, the FDA says, will save money,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?